RhumbLine Advisers’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.26M	Buy	76,408 +14,549	+24%	+$278K	﹤0.01%	2080
2025 Q4	$970K	Sell	61,859 -2,087	-3%	-$28.1K	﹤0.01%	2243
2025 Q3	$474K	Buy	63,946 +361	+0.6%	+$1.91K	﹤0.01%	2732
2025 Q2	$287K	Buy	63,585 +1,346	+2%	+$6K	﹤0.01%	3010
2025 Q1	$289K	Buy	62,239 +448	+0.7%	+$2.75K	﹤0.01%	2910
2024 Q4	$429K	Buy	61,791 +9,323	+18%	+$70K	﹤0.01%	2768
2024 Q3	$278K	Buy	52,468 +4,543	+9%	+$22.9K	﹤0.01%	3066
2024 Q2	$179K	Buy	47,925 +1,372	+3%	+$7K	﹤0.01%	3284
2024 Q1	$328K	Buy	46,553 +1,193	+3%	+$7.08K	﹤0.01%	2936
2023 Q4	$256K	Sell	45,360 -243	-0.5%	-$953	﹤0.01%	3060
2023 Q3	$218K	Buy	45,603 +578	+1%	+$3.72K	﹤0.01%	3116
2023 Q2	$308K	Sell	45,025 -1,148	-2%	-$7.42K	﹤0.01%	2997
2023 Q1	$360K	Buy	46,173 +2,324	+5%	+$16.2K	﹤0.01%	2556
2022 Q4	$334K	Buy	43,849 +887	+2%	+$7.39K	﹤0.01%	2636
2022 Q3	$351K	Buy	42,962 +2,412	+6%	+$22.2K	﹤0.01%	2654
2022 Q2	$392K	Buy	40,550 +16,358	+68%	+$164K	﹤0.01%	2620
2022 Q1	$339K	Buy	+24,192	New	+$336K	﹤0.01%	2597
2021 Q4	–	Sell	-9,233	Closed	-$206K	–	3008
2021 Q3	$206K	Buy	+9,233	New	+$265K	﹤0.01%	2906